$2125 | SAVE $375 | Single User
$2550 | SAVE $450 | Multi User
$3825 | SAVE $675 | Enterprise License

GLOBAL DRUG DISCOVERY MARKET FORECAST 2016-2024
[Report Updated: 24-03-2017]

Published by Inkwood Research: 24 Mar 2017 | 81175 | In Stock
Related Topics: Pain

Introduction

KEY FINDINGS

The global automotive paints and coatings market is projected to grow from .55 billion in 2017 to .73 billion by 2025 growing at a CAGR of 5.01% during the forecast period.

MARKET INSIGHTS

The automotive paints and coatings market is segmented on the basis of technology, coat type, vehicle type and geography. On the basis of coat type, the automotive paints and coatings market is segmented into base coat, electro coat, clear coat and primer. The automotive paints and coatings market by vehicle type is further segmented into passenger cars, light commercial vehicles and heavy commercial vehicles. On the basis of geography, the automotive paints and coatings market is segmented into Europe, Asia-Pacific, North America and Rest of the world.

An increase in demand for eco-friendly paints and coatings from the automotive industry and the booming automobile industry are major driving factors for the growth of the automotive paints and coatings market. On contrary, stringent regulations and policies by the government, environmental issues like VOC and CO2 emissions are restraining the market growth.

REGIONAL INSIGHTS

Asia Pacific automotive paints and coatings market holds the largest market share in the global automotive paints and coatings. Europe is projected to be the second largest market for automotive paints and coatings due to the fastest market growth during the forecast period. North America is estimated to grow throughout the forecast period.

COMPETITIVE INSIGHTS

The leading market players in the automotive paints and coatings market are Valspar, The Sherwin-Williams, RPM International, PPG Industries Inc., Nippon Paint Holdings Ltd, Kansai Paint Co. Ltd., Foretch Products Inc., BASF Coatings, Axalta Coating Systems and Akzonobel.

1. SANOFI

2. JOHNSON AND JOHNSON

3. ASTRAZENECA PLC

4. BAYER AG

5. BOEHRINGER INGELHEIM

6. PFIZER, INC.

7. GLAXOSMITHKLINE LLC

8. ELI LILY

9. MERCK & CO. INC.

10. ROCHE HOLDING AG

Table of Contents
for GLOBAL DRUG DISCOVERY MARKET FORECAST 2016-2024 [Report Updated: 24-03-2017]

  • 1. RESEARCH SCOPE

    1.1. STUDY GOALS

    1.2. SCOPE OF THE MARKET STUDY

    1.3. WHO WILL FIND THIS REPORT USEFUL?

    1.4. STUDY AND FORECASTING YEARS

    2. RESEARCH METHODOLOGY

    2.1. SOURCES OF DATA

    2.1.1. SECONDARY DATA

    2.1.2. PRIMARY DATA

    2.2. TOP DOWN APPROACH

    2.3. BOTTOM-UP APPROACH

    2.4. DATA TRIANGULATION

    3. EXECUTIVE SUMMARY

    4. MARKET OVERVIEW

    4.1. MARKET DRIVERS

    4.1.1. AGING POPULATION

    4.1.2. SPENDING ON HEALTHCARE HAS BEEN INCREASED

    4.1.3. INCREASE IN LIFESTYLE ORIENTED DISEASES & FATALITIES

    4.2. MARKET RESTRAINTS

    4.2.1. GOVERNMENT REGULATIONS DELAYING THE PROCESSES

    4.2.2. POOR ACCESS TO THE HEALTHCARE SERVICES IN DEVELOPING MARKETS

    4.2.3. MARKET IS SHIFTING FROM BRANDED TO GENERIC DRUGS

    4.3. MARKET CHALLENGES

    4.3.1. COST BARRIER FOR LOCAL PEOPLE IN EMERGING ECONOMIES

    4.4. MARKET OPPORTUNITIES

    4.4.1. EXTENSIVE R & D FOR NEW PRODUCT LAUNCHES

    5. BY TECHNOLOGY

    5.1. QPCR

    5.2. DNA MICROARRAYS

    5.3. PROTEIN MICROARRAYS

    5.4. HIGH-THROUGHPUT SCREENING

    5.5. MASS SPECTROMETRY

    5.6. GEL ELECTROPHORESIS

    5.7. CHROMATOGRAPHY

    5.8. PROTEIN AND NUCLEIC ACID ISOLATION

    5.9. OTHER TECHNOLOGIES

    6. KEY ANALYTICS

    6.1. PORTER’S FIVE FORCES ANALYSIS

    6.1.1. THREATS OF NEW ENTRANTS

    6.1.2. COMPETITIVE RIVALRY

    6.1.3. BARGAINING POWER OF BUYERS

    6.1.4. BARGAINING POWER OF SUPPLIERS

    6.1.5. THREAT OF SUBSTITUTE PRODUCTS

    6.2. VALUE CHAIN ANALYSIS

    6.3. KEY EXCERPTS OF THE STUDY

    6.3.1. RELAXATION IN THE REGULATIONS BY THE GOVERNMENT WHICH STOPS RESEARCHERS FROM DOING RESEARCH.

    6.3.2. MARKET LEADERS SHOULD OPEN UP THEIR BRANCHES AND RESEARCH LABS IN EMERGING MARKETS.

    6.4. PESTLE ANALYSIS

    6.5. OPPORTUNITY MATRIX

    6.6. VENDOR LANDSCAPE

    7. BY REGION

    7.1. NORTH AMERICA

    7.1.1. UNITED STATES (U.S.)

    7.1.2. CANADA

    7.2. EUROPE

    7.2.1. UNITED KINGDOM (UK)

    7.2.2. FRANCE

    7.2.3. GERMANY

    7.2.4. SPAIN

    7.2.5. ITALY

    7.2.6. REST OF EUROPE (ROE)

    7.3. ASIA PACIFIC

    7.3.1. INDIA

    7.3.2. CHINA

    7.3.3. JAPAN

    7.3.4. KOREA

    7.3.5. AUSTRALIA

    7.3.6. REST OF ASIA-PACIFIC (ROAPAC)

    7.4. REST OF THE WORLD (ROW)

    7.4.1. MIDDLE EAST AND NORTH AMERICA

    7.4.2. AFRICA

    8. COMPANY PROFILES

    8.1. SANOFI

    8.1.1. COMPANY OVERVIEW

    8.1.2. PRODUCT PORTFOLIO

    8.1.3. SWOT ANALYSIS

    8.1.4. STRATEGIC ANALYSIS

    8.2. JOHNSON AND JOHNSON

    8.2.1. COMPANY OVERVIEW

    8.2.2. PRODUCT PORTFOLIO

    8.2.3. SWOT ANALYSIS

    8.2.4. STRATEGIC ANALYSIS

    8.3. ASTRAZENECA PLC

    8.3.1. COMPANY OVERVIEW

    8.3.2. PRODUCT PORTFOLIO

    8.3.3. SWOT ANALYSIS

    8.3.4. STRATEGIC ANALYSIS

    8.4. BAYER AG

    8.4.1. COMPANY OVERVIEW

    8.4.2. PRODUCT PORTFOLIO

    8.4.3. SWOT ANALYSIS

    8.4.4. STRATEGIC ANALYSIS

    8.5. BOEHRINGER INGELHEIM

    8.5.1. COMPANY OVERVIEW

    8.5.2. PRODUCT PORTFOLIO

    8.5.3. SWOT ANALYSIS

    8.5.4. STRUCTURAL ANALYSIS

    8.6. PFIZER, INC.

    8.6.1. COMPANY OVERVIEW

    8.6.2. SWOT ANALYSIS

    8.6.3. STRATEGIC ANALYSIS

    8.7. GLAXOSMITHKLINE LLC

    8.7.1. COMPANY OVERVIEW

    8.7.2. PRODUCT PORTFOLIO

    8.7.3. SWOT ANALYSIS

    8.7.4. STRATEGIC ANALYSIS

    8.8. ELI LILY

    8.8.1. COMPANY OVERVIEW

    8.8.2. PRODUCT PORTFOLIO

    8.8.3. SWOT ANALYSIS

    8.8.4. STRATEGIC ANALYSIS

    8.9. MERCK & CO. INC.

    8.9.1. COMPANY OVERVIEW

    8.9.2. PRODUCT PORTFOLIO

    8.9.3. SWOT ANALYSIS

    8.9.4. STRATEGIC ANALYSIS

    8.10. ROCHE HOLDING AG

    8.10.1. COMPANY OVERVIEW

    8.10.2. PRODUCT PORTFOLIO

    8.10.3. SWOT ANALYSIS

    8.10.4. STRATEGIC ANALYSIS

    TABLE LIST

    TABLE# 1 FACT SHEET OF GLOBAL FATALITIES

    TABLE# 2 GLOBAL QPCR MARKET, BY REGION, 2016-2024, (IN $MILLION)

    TABLE# 3 GLOBAL DNA MICROARRAYS, BY REGION, 2016-2024, (IN $MILLION)

    TABLE# 4 GLOBAL PROTEIN MICROARRAYS, BY REGION, 2016-2024(IN $MILLION)

    TABLE# 5 GLOBAL HIGH THROUGHPUT SCREENING, BY REGION, 2016-2024(IN $MILLION)

    TABLE# 6 GLOBAL MASS SPECTROMETRY, BY REGION, 2016-2024(IN $MILLION)

    TABLE# 7 GLOBAL GEL ELECTROPHORESIS MARKET, BY REGION, 2016-2024, (IN $MILLION)

    TABLE# 8 GLOBAL CHROMATOGRAPHY MARKET, BY REGION, 2016-2024 (IN $MILLION)

    TABLE# 9 GLOBAL PROTEIN AND NUCLEIC ACID ISOLATION MARKET, BY REGION, 2016-2024 (IN $MILLION)

    TABLE# 10 GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, 2016-2024 (IN $MILLION)

    TABLE# 11 GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2016-2024, (IN $MILLION)

    TABLE# 12 FATALITY IN EUROPE IN 2012

    FIGURES LIST

    FIGURE# 1 GLOBAL DRUG DISCOVERY MARKET, 2016-2024, (IN $MILLION)

    FIGURE# 2 GLOBAL DRUG DISCOVERY MARKET SHARE, BY TECHNOLOGY, 2016 & 2024

    FIGURE# 3 GLOBAL QPCR MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 4 GLOBAL DNA MICROARRAYS MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 5 GLOBAL PROTEIN MICROARRAYS MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 6 GLOBAL HIGH THROUGHPUT SCREENING MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 7 GLOBAL MASS SPECTROMETRY MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 8 GLOBAL GEL ELECTROPHORESIS MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 9 GLOBAL CHROMATOGRAPHY MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 10 GLOBAL PROTEIN AND NUCLEIC ACID ISOLATION MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 11 GLOBAL OTHER TECHNOLOGIES MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 12 NORTH AMERICA DRUG DISCOVERY MARKET, 2016-2024, (IN $ MILLION)

    FIGURE# 13 COUNTRY-WISE MARKET SHARE, 2016

    FIGURE# 14 UNITED STATES DRUG DISCOVERY MARKET, 2016-2024, (IN $ MILLION)

    FIGURE# 15 CANADA DRUG DISCOVERY MARKET, 2016-2024, (IN $MILLION)

    FIGURE# 16 EUROPE DRUG DISCOVERY MARKET, 2016-2024, (IN $MILLION)

    FIGURE# 17 COUNTRY-WISE MARKET SHARE, 2016

    FIGURE# 18 UNITED KINGDOM DRUG DISCOVERY MARKET, 2016-2024, (IN $MILLION)

    FIGURE# 19 FRANCE DRUG DISCOVERY MARKET, 2016-2024, (IN $MILLION)

    FIGURE# 20 GERMAN DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 21 SPAIN DRUG DISCOVERY MARKET, 2016-2024, (IN $MILLION)

    FIGURE# 22 ITALY DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 23 REST OF EUROPE (ROE) DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 24 ASIA-PACIFIC DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 25 COUNTRY-WISE MARKET SHARE, 2016

    FIGURE# 26 INDIA DRUG DISCOVERY MARKET, 2016-2024, (IN $MILLION)

    FIGURE# 27 CHINA DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 28 JAPAN DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 29 KOREA DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 30 AUSTRALIA DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 31 REST OF ASIA-PACIFIC (ROAPAC) DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

    FIGURE# 32 REST OF THE WORLD (ROW) DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

List Of Tables
in GLOBAL DRUG DISCOVERY MARKET FORECAST 2016-2024 [Report Updated: 24-03-2017]

TABLE LIST


TABLE# 1 FACT SHEET OF GLOBAL FATALITIES

TABLE# 2 GLOBAL QPCR MARKET, BY REGION, 2016-2024, (IN $MILLION)

TABLE# 3 GLOBAL DNA MICROARRAYS, BY REGION, 2016-2024, (IN $MILLION)

TABLE# 4 GLOBAL PROTEIN MICROARRAYS, BY REGION, 2016-2024(IN $MILLION)

TABLE# 5 GLOBAL HIGH THROUGHPUT SCREENING, BY REGION, 2016-2024(IN $MILLION)

TABLE# 6 GLOBAL MASS SPECTROMETRY, BY REGION, 2016-2024(IN $MILLION)

TABLE# 7 GLOBAL GEL ELECTROPHORESIS MARKET, BY REGION, 2016-2024, (IN $MILLION)

TABLE# 8 GLOBAL CHROMATOGRAPHY MARKET, BY REGION, 2016-2024 (IN $MILLION)

TABLE# 9 GLOBAL PROTEIN AND NUCLEIC ACID ISOLATION MARKET, BY REGION, 2016-2024 (IN $MILLION)

TABLE# 10 GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, 2016-2024 (IN $MILLION)

TABLE# 11 GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2016-2024, (IN $MILLION)

TABLE# 12 FATALITY IN EUROPE IN 2012

List Of Figures, Charts and Diagrams
in GLOBAL DRUG DISCOVERY MARKET FORECAST 2016-2024 [Report Updated: 24-03-2017]

FIGURES LIST


FIGURE# 1 GLOBAL DRUG DISCOVERY MARKET, 2016-2024, (IN $MILLION)

FIGURE# 2 GLOBAL DRUG DISCOVERY MARKET SHARE, BY TECHNOLOGY, 2016 & 2024

FIGURE# 3 GLOBAL QPCR MARKET, 2016-2024 (IN $MILLION)

FIGURE# 4 GLOBAL DNA MICROARRAYS MARKET, 2016-2024 (IN $MILLION)

FIGURE# 5 GLOBAL PROTEIN MICROARRAYS MARKET, 2016-2024 (IN $MILLION)

FIGURE# 6 GLOBAL HIGH THROUGHPUT SCREENING MARKET, 2016-2024 (IN $MILLION)

FIGURE# 7 GLOBAL MASS SPECTROMETRY MARKET, 2016-2024 (IN $MILLION)

FIGURE# 8 GLOBAL GEL ELECTROPHORESIS MARKET, 2016-2024 (IN $MILLION)

FIGURE# 9 GLOBAL CHROMATOGRAPHY MARKET, 2016-2024 (IN $MILLION)

FIGURE# 10 GLOBAL PROTEIN AND NUCLEIC ACID ISOLATION MARKET, 2016-2024 (IN $MILLION)

FIGURE# 11 GLOBAL OTHER TECHNOLOGIES MARKET, 2016-2024 (IN $MILLION)

FIGURE# 12 NORTH AMERICA DRUG DISCOVERY MARKET, 2016-2024, (IN $ MILLION)

FIGURE# 13 COUNTRY-WISE MARKET SHARE, 2016

FIGURE# 14 UNITED STATES DRUG DISCOVERY MARKET, 2016-2024, (IN $ MILLION)

FIGURE# 15 CANADA DRUG DISCOVERY MARKET, 2016-2024, (IN $MILLION)

FIGURE# 16 EUROPE DRUG DISCOVERY MARKET, 2016-2024, (IN $MILLION)

FIGURE# 17 COUNTRY-WISE MARKET SHARE, 2016

FIGURE# 18 UNITED KINGDOM DRUG DISCOVERY MARKET, 2016-2024, (IN $MILLION)

FIGURE# 19 FRANCE DRUG DISCOVERY MARKET, 2016-2024, (IN $MILLION)

FIGURE# 20 GERMAN DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

FIGURE# 21 SPAIN DRUG DISCOVERY MARKET, 2016-2024, (IN $MILLION)

FIGURE# 22 ITALY DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

FIGURE# 23 REST OF EUROPE (ROE) DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

FIGURE# 24 ASIA-PACIFIC DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

FIGURE# 25 COUNTRY-WISE MARKET SHARE, 2016

FIGURE# 26 INDIA DRUG DISCOVERY MARKET, 2016-2024, (IN $MILLION)

FIGURE# 27 CHINA DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

FIGURE# 28 JAPAN DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

FIGURE# 29 KOREA DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

FIGURE# 30 AUSTRALIA DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

FIGURE# 31 REST OF ASIA-PACIFIC (ROAPAC) DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

FIGURE# 32 REST OF THE WORLD (ROW) DRUG DISCOVERY MARKET, 2016-2024 (IN $MILLION)

Additional Details

Publisher

Inkwood Research

Publisher Information

Inkwood Research's complete end-to-end spectrum of consulting and advisory service offerings driven by subject matter experts provide a comprehensive, research-based view crucial for overcoming market challenges that are not only sustainable over the long-term, but ones that truly drive growth upwards. Inkwood looks at a plethora of data points from diverse sources to show client: customer-centric value proposition ..…

Reference

81175 | 4455

Number of Pages

187

Report Format

PDF

Inkwood Research Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Orphan Drug Commercial Models: Sustaining the rare disease business
IntroductionChoosing the right commercial model for orphan drug successThe societal and commercial a...
01 May 2016 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Pay-for-Performance and Drug Pricing: Impact and Response of Pharma [2016]
IntroductionThe pay for performance agenda gathers pace as US payers rebel the cost of drugs.Pharma ...
01 Mar 2016 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Innovations in Drug Pricing and Reimbursement (2016)
IntroductionIs the drug pricing bubble about to burst?Drug costs are becoming unaffordable and draco...
01 Feb 2016 by FirstWord Pharma USD $1,866 (normally
USD $2,195)
More Info
SAVE 15% today! Drug Delivery - Innovations, trends, and their impact on pharma
IntroductionWhy you need Drug Delivery - Innovations, trends, and their impact on pharmaRevolutionar...
01 Nov 2015 by FirstWord Pharma USD $1,866 (normally
USD $2,195)
More Info
SAVE 15% today! Physician Views: Which companies excel in diabetes drug marketing and why?
Scope With both the insulin and non-insulin segments of the diabetes market expected to become more ...
01 May 2015 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Trends and Innovations in Drug Pricing
IntroductionFirstWord’s Trends and Innovations in Drug Pricing report dissects international trends ...
01 Jan 2015 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Orphan Drug Market Access: Payer Insights on the Present and Future
IntroductionOrphan Drug Market Access: Payer Insights on the Present and Future is a report that exa...
14 Oct 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: With drug developers on the brink of Phase III for NASH, how large is the actual market opportunity?
Scope While no drugs are approved for non-alcoholic steatohepatitis (NASH), at least eight agents ha...
04 Aug 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: As Tecfidera approaches a critical juncture in Europe, how are neurologist perceptions towards Biogen Idec's MS drug shaping up?
ScopeSales of Biogen Idec’s multiple sclerosis therapy Tecfidera may continue to exceed initial expe...
01 Nov 2013 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: Recent developments in US diabetes market – impact of safety concerns & emergence of SGLT-2 drug class
ScopeWith the diabetes market an important therapeutic area for a host of pharmaceutical manufacture...
01 Jun 2013 by FirstWord Pharma USD $591 (normally
USD $695)
More Info

This report is published by Inkwood Research

Inkwood Research's complete end-to-end spectrum of consulting and advisory service offerings driven by subject matter experts provide a comprehensive, research-based view crucial for overcoming market challenges that are not only sustainable over the long-term, but ones that truly drive growth upwards. Inkwood looks at a plethora of data points from diverse sources to show client: customer-centric value proposition ..…

Download Free Report Summary PDF

GLOBAL DRUG DISCOVERY MARKET FORECAST 2016-2024 [Report Updated: 24-03-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...